an 8week, Multi-Center, Randomized, Double Blind, Placebo-Controlled, Parallel Group, Fixed Dose, Dose-Finding Study to Assess the Efficacy and Safety of SK3530 [mirodenafil] in Patients With Erectile Dysfunction.
Phase of Trial: Phase II
Latest Information Update: 20 Nov 2006
At a glance
- Drugs Mirodenafil (Primary)
- Indications Erectile dysfunction
- Focus Therapeutic Use
- Sponsors SK Chemicals
- 20 Nov 2006 New trial record.